Thioridazine induces apoptosis of multidrug-resistant mouse lymphoma cells transfected with the human ABCB1 and inhibits the expression of P-glycoprotein

Anticancer Research

Volumn 31, Issue 12, 2011, Pages 4201-4205

  Spengler, Gabriella ^a,c   Molnar, Joseph ^a   Viveiros, Miguel ^b,d   Amaral, Leonard ^b,c,d  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^c INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

^d EUROPEAN COMMISSION   (Belgium)

Author keywords

ABCB1 transporter; Apoptosis; MDR mouse T lymphoma cells; Multidrug resistant cancer cells; P glycoprotein; Phenothiazines; Thioridazine

Indexed keywords

ANTINEOPLASTIC AGENT; ETHIDIUM BROMIDE; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1; THIORIDAZINE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; HUMAN; LYMPHOMA; LYMPHOMA CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CHEMOTHERAPY, ADJUVANT; DOPAMINE ANTAGONISTS; DRUG RESISTANCE, MULTIPLE; DRUG SYNERGISM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA; MICE; P-GLYCOPROTEIN; THIORIDAZINE; TRANSFECTION;

EID: 84855160972     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61(2): 69-90, 2011.
2. Amaral L, Engi H, Viveiros M and Molnar J: Comparison of multidrug-resistant efflux pumps of cancer and bacterial cells with respect to the same inhibitory agents. In Vivo 21: 237-244, 2007. (Pubitemid 46534275)
3. Moitra K and Dean M: Evolution of ABC transporters by gene duplication and their role in human disease. Biol Chem 392: 29-37, 2011.
4. Wu CP, Calcagno AM and Ambudkar SV: Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies. Curr Mol Pharmacol 1: 93-105, 2008
5. Ferguson LR and De Flora S: Multiple drug resistance, antimutagenesis and anticarcinogenesis. Mutat Res 591: 24-33, 2005. (Pubitemid 41654837)
6. Higgins CF: ABC transporters: from microorganisms to man. Annu Rev Cell Biol 8: 67-113, 1992.
7. Sarkadi B, Homolya L, Szakács G and Váradi A: Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. Physiol Rev 86: 1179-1236, 2006. (Pubitemid 44521651)
8. Szakács G, Annereau JP, Lababidi S, Shankavaram U, Arciello A, Bussey KJ, Reinhold W, Guo Y, Kruh GD, Reimers M, Weinstein JN and Gottesman MM: Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells. Cancer Cell 6: 129-137, 2004. (Pubitemid 39485685)
9. Gérard Taurand: Phenothiazine and Derivatives. In: Ullmann's Encyclopedia of Industrial Chemistry, Wiley-VCH, Weinheim, 2005.
10. Ehrlich P: Papers reprinted. In: The Collected Papers of Paul Ehrlich. Himmelweit F, Marquardt M and Dale HH (eds.), Vol III. Chemotherapy: London: Pergamon pp. 505-518, 1913.
11. Healy D: The Creation of Pharmacology. Harvard University Press, Boston, MA, 2002.
12. Kristiansen JE and Amaral L: The potential management of resistant infections with non-antibiotics. J Antimicrob Chemother 40: 319-327, 1997. (Pubitemid 27437949)
13. Amaral L and Kristiansen JE: Phenothiazines: an alternative to conventional therapy for the initial management of suspected multidrug resistant tuberculosis. A call for studies. Int J Antimicrob Agents 14: 173-176, 2000. (Pubitemid 30201540)
14. Amaral L, Kristiansen JE, Viveiros M and Atouguia J: Activity of phenothiazines against antibiotic-resistant Mycobacterium tuberculosis: a review supporting further studies that may elucidate the potential use of thioridazine as anti-tuberculosis therapy. J Antimicrob Chemother 47: 505-511, 2001.
15. Amaral A, Kristiansen JE: Phenothiazines: potential management of Creutzfeldt-Jacob disease and its variants. Int J Antimicrob Agents 18: 411-417, 2001.
16. Amaral L, Viveiros M and Kristiansen JE: Phenothiazines: potential alternatives for the management of antibiotic resistant infections of tuberculosis and malaria in developing countries. Trap Med Int Health 6: 1016-1022, 2001. (Pubitemid 34008769)
17. Darkin S, McQuillan J and Ralph RK: Chlorpromazine: a potential anticancer agent? Biochem Biophys Res Commun 125: 184-191, 1984. (Pubitemid 15215864)
18. Akiyama S, Shiraishi N, Kuratomi Y, Nakagawa M and Kuwano M: Circumvention of multiple-drug resistance in human cancer cells by thioridazine, trifluoperazine, and chlorpromazine. J Natl Cancer Inst 76: 839-844, 1986. (Pubitemid 16121940)
19. Sagar PS, Das UN, Koratkar R, Ramesh G, Padma M and Kumar GS: Cytotoxic action of cis-unsaturated fatty acids on human cervical carcinoma (HeLa) cells: relationship to free radicals and lipid peroxidation and its modulation by calmodulin antagonists. Cancer Lett 63: 189-198, 1992.
20. Aas AT, Brun A, Pero RW and Salford LG: Chlorpromazine in combination with nitrosourea inhibits experimental glioma growth. Br J Neurosurg 8: 187-192, 1994. (Pubitemid 24160003)
21. Hait WN, Gesmonde JF and Lazo JS: Effect of anti-calmodulin drugs on the growth and sensitivity of C6 rat glioma cells to bleomycin. Anticancer Res 14: 1711-1721, 1994.
22. Jones GR: Successful cancer therapy with promethazine: the rationale. Med Hypotheses 46: 25-29, 1996.
23. Rho SB, Kim BR and Kang S: A gene signature-based approach identifies thioridazine as an inhibitor of phosphatidylinositol-3′kinase (PI3K)/AKT pathway in ovarian cancer cells. Gynecol Oncol 120: 121-127, 2011.
24. Gil-Ad I, Shtaif B, Levkovitz Y, Nordenberg J, Taler M, Korov I and Weizman A: Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth. Oncol Rep 15: 107-112, 2006.
25. Strobl JS and Peterson VA: Tamoxifen-resistant human breast cancer cell growth: inhibition by thioridazine, pimozide and the calmodulin antagonist, W-13. J Pharmacol Exp Ther 263: 186-193, 1992.
26. Mayur YC, Peters GJ, Prasad VV, Lemo C and Sathish NK: Design of new drug molecules to be used in reversing multidrug resistance in cancer cells. Curr Cancer Drug Targets 9: 298-306, 2009.
27. 2+/CaM- dependent protein kinase cascade in health and disease. Subcell Biochem 45: 169-214, 2007.
28. Mayur YC, Jagadeesh S and Thimmaiah KN: Targeting calmodulin in reversing multi-drug resistance in cancer cells. Mini Rev Med Chem 6: 1383-1389, 2006. (Pubitemid 44890545)
29. Rodriguez-Mora O, LaHair MM, Howe CJ, McCubrey JA and Franklin RA: Calcium/calmodulin-dependent protein kinases as potential targets in cancer therapy. Expert Opin Ther Targets 9: 791-808, 2005. (Pubitemid 41131679)
30. Amaral L, Kristiansen JE, Abebe LS and Millett W: Inhibition of the respiration of multidrug-resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: potential use for initial therapy of freshly diagnosed tuberculosis. J Antimicrob Chemother 38: 1049-1053, 1996. (Pubitemid 27073284)
31. Spengler G, Evaristo M, Handzlik J, Serly J, Molnár J, Viveiros M, Kiéc-Kononowicz K and Amaral L: Biological activity of hydantoin derivatives on P-glycoprotein (ABCB1) of mouse lymphoma cells. Anticancer Res 30: 4867-4871, 2010.
32. Spengler G, Ramalhete C, Martins M, Martins A, Serly J, Viveiros M, Molnár J, Duarte N, Mulhovo S, Ferreira MJ and Amaral L: Evaluation of cucurbitane-type triterpenoids from Momordica balsamina on P-glycoprotein (ABCB1) by flow cytometry and real-time fluorometry. Anticancer Res 29: 3989-3993, 2009.
33. Spengler G, Viveiros M, Martins M, Rodrigues L, Martins A, Molnar J, Couto I and Amaral L: Demonstration of the activity of P-glycoprotein by a semi-automated fluorometric method. Anticancer Res 29: 2173-2177, 2009.
34. Pastan I, Gottesman MM, Ueda K, Lovelace E, Rutherford AV and Willingham MC: A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc Natl Acad Sci USA 85: 4486-4490, 1988.
35. Choi K, Frommel TO, Stern RK, Perez CF, Kriegler M, Tsuruo T and Roninson IB: Multidrug resistance after retroviral transfer of the human MDR1 gene correlates with P-glycoprotein density in the plasma membrane and is not affected by cytotoxic selection. Proc Natl Acad Sci USA 88: 7386-7390, 1991. (Pubitemid 21915156)
36. Ordway D, Hohmann J, Viveiros M, Viveiros A, Molnar J, Leandro C, Arroz MJ, Gracio MA and Amaral L: Carpobrotus edulis methanol extract inhibits the MDR efflux pumps, enhances killing of phagocytosed S. aureus and promotes immune modulation. Phytother Res 17: 512-519, 2003. (Pubitemid 36605904)
37. Mucsi I, Varga A, Kawase M, Motohashi N and Molnar J: Interaction between various resistance modifiers and apoptosis inducer 12H-benzo[alpha] phenothiazine. Anticancer Res 22(5): 2833-2836, 2002. (Pubitemid 36069321)